Skip to main content
Clinical Trials/NCT06286761
NCT06286761
Recruiting
Not Applicable

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Metabolism Research

Bettina Mittendorfer1 site in 1 country100 target enrollmentMay 8, 2024
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Bettina Mittendorfer
Enrollment
100
Locations
1
Primary Endpoint
Validation and reproducibility testing for endothelial cell collection
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases (obesity, pre-diabetes and type-2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, cardiovascular disease, etc.), nutrition, and metabolism (the process by which a substance is handled in your body) at the University of Missouri. As technology changes and we start to use new testing methods, it is necessary to compare results from old tests, equipment and devices and new tests, equipment, or devices and the reproducibility of these measurements to make sure we are getting accurate results. Reproducibility means performing the same test more than once to see if the same results can be achieved each time.

Registry
clinicaltrials.gov
Start Date
May 8, 2024
End Date
March 1, 2028
Last Updated
9 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Bettina Mittendorfer
Responsible Party
Sponsor Investigator
Principal Investigator

Bettina Mittendorfer

Senior Associate Dean for Research; Professor, Medicine & Nutrition; NextGen Director of Clinical and Translational Sciences Unit

University of Missouri-Columbia

Eligibility Criteria

Inclusion Criteria

  • ≥18 and ≤75 years of age
  • body mass index ≥18.5 and ≤45 kg/m2
  • Weight stable (i.e., ≤3% change)
  • ≤150 min of structured exercise/week for at least 2 months before entering the study
  • Blood glucose: \< 126 mg/dl fasted, \< 200 mg/dl with 2 hour oral glucose tolerance testing
  • Hemoglobin A1C (HbA1C) ≤6.5%
  • Dyslipidemia triglycerides ≥125 mg/dL
  • No chronic kidney disease
  • Not vegan or vegetarian or on high protein diet (e.g. Atkins) or supplements that are not allowed
  • No intolerance or allergies to study diet ingredients

Exclusion Criteria

  • \<18 and \>75 years of age
  • body mass index \<18.5 or \>45 kg/m2
  • history of or current significant organ system dysfunction (e.g., heart disease, stroke, diabetes, cancer in remission for \<5 years, dementia, chronic kidney disease)
  • allergies or intolerances to meal ingredients, vegans or vegetarians
  • use of medications that could confound the study outcomes (e.g., anti-inflammatories, immune modulators, etc)
  • take dietary supplements (e.g., certain pre- and pro-biotics, fiber, fish oil supplements)
  • engaged in regular structured exercise \>150 min per week
  • alcohol use disorder as defined by the National Institute of Alcohol Abuse and Alcoholism or use of controlled substances
  • pregnant women
  • persons who use tobacco

Outcomes

Primary Outcomes

Validation and reproducibility testing for endothelial cell collection

Time Frame: through study completion, an average of 10 weeks

endothelial cell quantity collected

Validation and reproducibility testing for mixed meal ingestion

Time Frame: through study completion, an average of 10 weeks

tolerability and palatability of meal type (protein concentration, carbohydrate concentration)

Validation and reproducibility testing for blood assays

Time Frame: through study completion, an average of 10 weeks

insulin, C-peptide, glucagon, substrates (free fatty acids, glucose, ketone bodies) and biomarkers of substrate metabolism (e.g., cytokines and adipokines)

Validation and reproducibility testing for glucose tolerance testing

Time Frame: through study completion, an average of 10 weeks

glucose levels

Validation and reproducibility testing for DEXA

Time Frame: through study completion, an average of 10 weeks

body composition analysis

Validation and reproducibility testing for MRS

Time Frame: through study completion, an average of 10 weeks

body composition analysis

Validation and reproducibility testing for MRI

Time Frame: through study completion, an average of 10 weeks

body composition analysis

Study Sites (1)

Loading locations...

Similar Trials